Global CAR T Cell Therapy Market Research 2022: Opportunity & Clinical Pipeline Insights to 2028 - Insight On More Than 600 CAR T Cell Therapies In Clinical Trials
June 16, 2022 04:33 ET
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
Outlook on the KRAS Inhibitors Global Market to 2028 - Key Drivers and Challenges
April 27, 2022 05:28 ET
|
Research and Markets
Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The advancement in...
Outlook on the CAR-T Cell Therapies Industry - In-depth Review of the Various Patents and Affiliated IP Documents
April 25, 2022 05:58 ET
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions,...
Gamma Delta T Cell Therapy Represents One of the Most Promising T Cell Therapies in Clinical Development
April 21, 2022 07:38 ET
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Gamma Delta T Cell Cancer Therapy Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The...
Global $33+ Billion CAR-T Cell Therapy Markets, 2017-2021 & 2022-2027: Focus on Yescarta, Kymriah, Tecartus, Breyanzi, Abecma
April 05, 2022 04:33 ET
|
Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market, By Product Type, By Tumor Type, By Indication, By Treatment Type, By Targeted Antigen, By End User, By Region,...
Global Car T Cell Therapy Market (2021 to 2028) - Size, Share, Outlook, and Opportunity Analysis
February 14, 2022 05:43 ET
|
Research and Markets
Dublin, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The "Car T Cell Therapy Market" report has been added to ResearchAndMarkets.com's offering. Chimeric antigen receptor (CAR) T-cell therapy is a type of...
Global CAR T-cell Therapy Market (2021 to 2031) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts
January 18, 2022 06:58 ET
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to...
Regulatory T-Cell Therapies Market, 2035
January 11, 2022 04:58 ET
|
Research and Markets
Dublin, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The "Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035" report has...
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research & Developments, 2018-2020 & 2021-2026
December 17, 2021 07:38 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.com's...
$4 Billion Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Market Outlook, 2028
December 08, 2021 07:18 ET
|
Research and Markets
Dublin, Dec. 08, 2021 (GLOBE NEWSWIRE) -- The "Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. Market...